Equities research analysts expect that Trupanion Inc (NASDAQ:TRUP) will post sales of $97.40 million for the current quarter, Zacks reports. Three analysts have provided estimates for Trupanion’s earnings, with the highest sales estimate coming in at $97.51 million and the lowest estimate coming in at $97.20 million. Trupanion reported sales of $78.16 million during the same quarter last year, which would suggest a positive year over year growth rate of 24.6%. The firm is expected to report its next quarterly earnings report on Thursday, November 14th.
On average, analysts expect that Trupanion will report full year sales of $379.10 million for the current year, with estimates ranging from $378.70 million to $379.61 million. For the next fiscal year, analysts expect that the company will report sales of $453.65 million, with estimates ranging from $447.00 million to $460.55 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that that provide coverage for Trupanion.
Trupanion (NASDAQ:TRUP) last issued its earnings results on Tuesday, July 30th. The financial services provider reported ($0.06) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.03) by ($0.03). Trupanion had a negative net margin of 0.68% and a negative return on equity of 1.77%. The firm had revenue of $92.20 million during the quarter, compared to analyst estimates of $91.17 million. During the same period last year, the business earned ($0.01) EPS. The firm’s revenue was up 24.8% compared to the same quarter last year.
In other news, insider Darryl Rawlings sold 4,000 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $24.62, for a total value of $98,480.00. Following the completion of the sale, the insider now directly owns 1,465,759 shares in the company, valued at $36,086,986.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CRO Margaret Tooth sold 750 shares of the business’s stock in a transaction on Tuesday, June 18th. The stock was sold at an average price of $34.69, for a total transaction of $26,017.50. The disclosure for this sale can be found here. Insiders sold 46,350 shares of company stock valued at $1,437,193 over the last quarter. Corporate insiders own 13.61% of the company’s stock.
Several institutional investors have recently modified their holdings of the company. Gilder Gagnon Howe & Co. LLC acquired a new position in Trupanion during the 1st quarter valued at $5,702,000. Clearbridge Investments LLC grew its holdings in Trupanion by 38.6% during the 1st quarter. Clearbridge Investments LLC now owns 1,220,505 shares of the financial services provider’s stock worth $39,959,000 after acquiring an additional 339,812 shares during the last quarter. Bank of America Corp DE grew its holdings in Trupanion by 1.4% during the 4th quarter. Bank of America Corp DE now owns 114,394 shares of the financial services provider’s stock worth $2,912,000 after acquiring an additional 1,622 shares during the last quarter. O Brien Greene & Co. Inc bought a new stake in Trupanion during the 1st quarter worth about $655,000. Finally, New York State Common Retirement Fund lifted its position in Trupanion by 0.6% during the 1st quarter. New York State Common Retirement Fund now owns 65,526 shares of the financial services provider’s stock valued at $2,145,000 after purchasing an additional 410 shares during the period. Institutional investors and hedge funds own 97.80% of the company’s stock.
NASDAQ:TRUP traded down $1.11 during trading hours on Tuesday, hitting $24.50. 17,503 shares of the company were exchanged, compared to its average volume of 359,566. The stock has a market capitalization of $871.84 million, a price-to-earnings ratio of -814.33 and a beta of 1.31. Trupanion has a 52-week low of $22.38 and a 52-week high of $39.91. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.80 and a quick ratio of 1.80. The company’s 50 day moving average price is $31.00 and its 200-day moving average price is $31.68.
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Read More: Depreciation
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.